Sarah Fredriksson
Aqilion’s CEO participated at the Expert Insights session of the BioStock Investor Meeting. During the interview, she discussed the company’s recent deal with Merck and gave insights on dealmaking in the biotech world.
Watch the interview with Aqilion’s CEO Sarah Fredriksson below.
We cover early-stage, growth-stage and late-stage investments. From business angels and seed investors driving medical breakthroughs, to investments empowering promising...
The Nordic region’s leading forum for early-stage and growth-phase life science companies. The Summit bridges innovation and capital by providing...
Lås upp vårt premium-innehåll: Bli prenumerant!
Skapa konto
